Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News on Diabetes

US drug maker to slash some insulin prices, expand cost cap

President Joe Biden hails move by Eli Lilly as a ‘big deal’, calling on other manufacturers to also reduce prices.

Al Jazeera

Eli Lilly plans to slash prices of some older insulins, expand cost cap

Lawmakers and patient advocates have been pressuring drugmakers to take action on soaring drug prices.

Chicago Sun-Times

Eli Lilly is capping customers’ insulin costs at $35

Eli Lilly & Co. is capping out-of-pocket costs for insulin at $35 a month, following a public plea from President Joe Biden for lower prices of the diabetes treatment for all Americans.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

France steps up monitoring of diabetes drug used for weight loss

The French drug safety agency on Wednesday announced it was stepping up monitoring of Ozempic, a diabetes drug promoted by influencers on social networks who flaunt its weight-loss properties. As well as health concerns, the authorities say the increased demand could jeopardise access for legitimate diabetic patients.

Radio France Internationale

Killer parents who left daughter to live and die in squalor 'unfit for animal' jailed

The parents of Kaylea Titford, 16, who weighed 22st 13lbs when she was found dead in her bedroom described as "unfit for any animal" have been sentenced at crown court this afternoon

Daily Mirror

Diabetes Giant Eli Lilly Slashes Insulin Prices 70% In A Move Its CEO Calls 'Aggressive'

Eli Lilly announced a 70% price cut for most of its insulins Wednesday in a move its CEO described as "aggressive." Eli Lilly stock jumped.

Investors Business Daily

Under pressure, Eli Lilly cuts insulin prices 70%

Drugmaker Eli Lilly says it's cutting the price of one insulin to below 1990s levels.

Axios

Read news from The Economist, FT, and more,
with one subscription

Lilly plans to slash some insulin prices, expand cost cap

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay when they fill prescriptions

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

The Independent UK

How use of diabetes drug Ozempic for weight loss has led to a shortage: 'Let the diabetics have their drugs'

Ozempic has been catapulted into the public eye in recent months as celebrities and wellness influencers started taking it for weight loss. But Ozempic is a diabetes drug — and the craze has led to a shortage, leaving those who need it for Type 2 diabetes at a loss.

Tribune News Service

German minister calls for ban on advertising junk food to children

Cem Özdemir said measure would help protect children from obesity and diabetes

The Guardian - UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

CBS '60 Minutes' Story Turns FDA Headlights On Diabetes and Weight Loss Drug Stock

Growth stock Novo Nordisk is showing strength after FDA approval of breakthrough oral drug for type 2 diabetes. Shares are in a base.

Investors Business Daily

What is the new slimming jab, how it works and how to get it - according to an expert

Pharmacist Navin Khosla gives the low-down on the new drug which is said to boost weight loss

Wales Online

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

Dynamite News

Study reveals gestational diabetes, preeclampsia linked to slower biological development in infants

According to a new study conducted by USC, gestational diabetes and preeclampsia may be associated with poorer biological development in babies. Read further on Dynamite News:

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

Get all your
news in one place.

100’s of premium titles.
One news app.

Newcastle Herald

How Will beat type 2 diabetes with diet and exercise

'I stopped eating fast food from that day on.'

Fortune

Continuous glucose monitors are trendy wearables—but how useful are they? Here's what experts say

There isn't much research to back up glucose monitoring for the average person.

The Independent UK

What is ‘Ozempic face’? Doctors warn about facial ageing side effect of diabetes medications

“Weight loss may turn back your biological age, but it tends to turn your facial clock forward,” one dermatologist says

The Independent UK

Baby had dangerously low blood sugar levels over three days, Letby trial told

Nurse Lucy Letby is accused of adding artificial insulin to a bag of intravenous liquid the infant was receiving at the Countess of Chester Hospital.

Tribune News Service

On Nutrition: Readers ask about cheese, grapes

Wendy M from Tucson, Arizona, writes: "I have recently read that a study has concluded that cheese does not raise cholesterol levels. So is it now OK to eat as much cheese (read: pizza) as we want?"

The Independent UK

The ‘next Ozempic’ became a social media sensation. Then everything changed

Liverpool Echo

Care home remains in special measures as residents still at risk

Care Quality Commission officials remain unimpressed by the care at Millvina House

1 … 59 60 61 62

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Manchester Crown Court

Care Quality Commission

84 stories

Countess of Chester Hospital

82 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.